Stay updated on Nivolumab and Ipilimumab Combination Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Ipilimumab Combination Clinical Trial page.

Latest updates to the Nivolumab and Ipilimumab Combination Clinical Trial page
- Check5 days agoChange DetectedRevision updated to v3.4.3. Melanoma and related topics (MedlinePlus Genetics) were removed from the related topics.SummaryDifference0.1%

- Check13 days agoChange DetectedAdded Melanoma as a condition tag and included a MedlinePlus Genetics related topics link on the study page.SummaryDifference0.1%

- Check20 days agoChange DetectedAdded Melanoma and MedlinePlus Genetics to the related topics section.SummaryDifference0.1%

- Check34 days agoChange DetectedAdded Revision: v3.4.2. Removed the funding lapse notice and the prior Revision: v3.4.1.SummaryDifference0.3%

- Check41 days agoChange DetectedAn administrative government funding notice was added and the site revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check48 days agoChange DetectedMinor UI and metadata updates were applied: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0 were added, while Melanoma and related topics such as MedlinePlus Genetics were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Nivolumab and Ipilimumab Combination Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Ipilimumab Combination Clinical Trial page.